Helen Horsley
UCB Pharma (United Kingdom)(GB)
Publications by Year
Research Areas
Synthetic Organic Chemistry Methods, Crystallization and Solubility Studies, X-ray Diffraction in Crystallography, Chemical synthesis and alkaloids, Rheumatoid Arthritis Research and Therapies
Most-Cited Works
- → Synthesis and Structure−Activity Relationships of Long-acting β2Adrenergic Receptor Agonists Incorporating Metabolic Inactivation: An Antedrug Approach(2010)98 cited
- → Nanoparticle Transport in Epithelial Cells: Pathway Switching Through Bioconjugation(2013)61 cited
- → Uptake and transport of B 12 -conjugated nanoparticles in airway epithelium(2013)42 cited
- → A two-directional strategy for the diversity-oriented synthesis of macrocyclic scaffolds(2012)37 cited
- → An orally available small molecule that targets soluble TNF to deliver anti-TNF biologic-like efficacy in rheumatoid arthritis(2022)37 cited
- → Total Synthesis of (−)-Histrionicotoxin 285A and (−)-Perhydrohistrionicotoxin(2008)33 cited
- → Investigation of conjugate addition/intramolecular nitrone dipolar cycloadditions and their use in the synthesis of dendrobatid alkaloid precursorsNitrone dipolar cycloaddition routes to piperidines and indolizidines. Part 10. For part 9, see ref. 1.(2004)30 cited
- → Discovery of a Potent, Orally Bioavailable PI4KIIIβ Inhibitor (UCB9608) Able To Significantly Prolong Allogeneic Organ Engraftment in Vivo(2018)21 cited
- → Achieving multi-isoform PI3K inhibition in a series of substituted 3,4-dihydro-2H-benzo[1,4]oxazines(2008)19 cited
- → Aryl–Aryl Bond Formation by the Fluoride‐Free Cross‐Coupling of Aryldisiloxanes with Aryl Bromides(2011)17 cited